---
layout: single
author_profile: true
title: "Business Trip Report - Korea @ Sep-2025"
date: Sun Jan  4 18:20:08 PST 2026
last_modified_at: Sun Jan  4 18:23:08 PST 2026
permalink: /report/biz-trip/2025/sep
categories:
 - report
tags:
 - business trip
toc: true
toc_label: "&nbsp;Table of Contents"
toc_icon: "fa-solid fa-music"
toc_sticky: true
---

posted: {{ page.date| date: "%d-%b-%Y" }}
&amp;
updated: {{ page.last_modified_at| date: "%d-%b-%Y" }}
{: .notice--primary}

# Trip Overview

**Korea â€¢ September 14-27, 2025 â€¢ Sunghee Yun**

Landmark 13-night trip featuring breakthrough VC engagement and Silicon Valley network expansion. During this trip, Sunghee
- secured **Path Way Investment commitment for Series A**
- obtained **StartX program endorsement from Andrew Radin** (AI Head @ StartX)
- worked on **â‚©500M angel investment** from Jinsul Joo
- delivered highly successful AI seminars at **POSTECH, Korea University Business School, and SNU EE**
- participated in **3-day G-Quantum Bio Forum** with critical networking outcomes
- gained comprehensive regulatory and legal insights for medical device approval
- expanded Korean medicine (í•œì˜í•™) collaboration network

# Basic Logistics

**Dates** - September 14-27, 2025 (13 nights)

**Flights**
- **Outbound** - OZ 211, SFO â†’ ICN (departed Sep 14 @ 11:30pm PDT, arrived Sep 16 @ 4:30am KST)
- **Return** - OZ 212, ICN â†’ SFO (departed Sep 27 @ 8:55pm KST, arrived Sep 27 @ 3:30pm PDT)

**Base** - Suji, Gyeonggi-do

**Regional Trips**
- **Sep 17** - Day trip to Pohang
  - KTX-ì‚°ì²œ 4031: Gwangmyeong Station â†’ Pohang Station (8:54am â†’ 10:55am)
  - KTX-ì‚°ì²œ 254: Pohang Station â†’ Gwangmyeong Station (9:36pm â†’ 11:48pm)
- **Sep 22-24** - 2-night stay in Suwon for G-Quantum Bio Forum
  - Base: Courtyard Marriott Suwon

# ACTION ITEMS

| Owner | Deliverable | Deadline | Status |
|-------|-------------|----------|--------|
| Sunghee Yun | **Submit StartX program application** with Andrew Radin's endorsement | Q4-2025 | <span style="color: blue;">In Progress</span> |
| Sunghee Yun / Kee-hyun Paik | **Execute USD 140k angel investment** - terms finalized | Oct-2025 | **COMPLETED** |
| Sunghee Yun / Jin Young Heo | **Investigate MFDS biochip medical equipment approval process** - specific procedures and documentation requirements | Oct-2025 | <span style="color: blue;">In Progress</span> |
| Sunghee Yun / Ghayoung Lee | **Submit first draft IRB proposal to SNUBH** - initiate iterative process (per ì†¡ì¬ì§„'s advice) | Oct-2025 | <span style="color: blue;">In Progress</span> |
| Jin Young Heo / Sunghee Yun | **Prepare press materials for ì¡°ì‹œì˜** (Asia Economy) - execute frequent media exposure strategy | Ongoing | <span style="color: blue;">In Progress</span> |
| Sunghee Yun | **Follow up with Path Way Investment** on Series A timeline and requirements | Q2-2026 | <span style="color: blue;">In Progress</span> |
| Sunghee Yun | **Coordinate with SNU EE faculty** (í™ìš©íƒ, ê¹€ì˜ë¯¼) on K-PAI and Erudio Bio collaboration | Q4-2025 | <span style="color: red;">Pending</span> |
| Sunghee Yun | **Follow up with Prof. í•œìˆ˜í¬** (POSTECH) on robotics/AI collaboration potential | Q4-2025 | <span style="color: red;">Pending</span> |
| Sunghee Yun | **Meet ê¹€ì†Œì—°** (Money Today) in Silicon Valley as discussed | Q4-2025 | **COMPLETED** |
| Sunghee Yun / Jin Young Heo | **Develop customer story narratives** based on Sep 20 meeting with í™©í˜œë ¨ | Oct-2025 | <span style="color: blue;">In Progress</span> |
| Jin Young Heo / Sunghee Yun | **Apply regulatory/legal insights from G-Quantum Bio seminar** to MFDS approval strategy | Ongoing | <span style="color: blue;">In Progress</span> |
| Sunghee Yun | **Explore Pion Corporation technical partnership** with ì „ì°¬ì„ | Q4-2025 | <span style="color: red;">Pending</span> |
| Sunghee Yun | **Continue Korean Medicine AI TF advisory role** and explore collaboration models | Ongoing | <span style="color: green;">Active</span> |

# MILESTONES & TIMELINE

**Immediate (Sep-Oct 2025):**
- âœ… Andrew Radin StartX endorsement obtained
- âœ… Path Way Investment Series A commitment secured
- âœ… USD 140k angel investment terms finalized
- âœ… â‚©500M angel investment secured for Korea entity
- âœ… Comprehensive MFDS/KFDA regulatory pathway understanding achieved
- âœ… Biochip medical equipment categorization confirmed
- ğŸ”„ StartX application submission
- ğŸ”„ SNUBH IRB first draft submission (iterative process initiated)
- ğŸ”„ MFDS approval process investigation

**Short-term (Q4 2025):**
- StartX program application and acceptance
- Angel investments execution (USD 140k + â‚©500M)
- MFDS biochip medical equipment regulatory pathway defined
- SNUBH IRB approval progress (iterative submissions)
- Press materials prepared and distributed
- Korean Medicine AI collaboration model developed

**Medium-term (2026):**
- Series A fundraising round with Path Way Investment participation
- MFDS approval process initiated for VSA platform
- K-PAI and academic collaborations formalized (SNU, POSTECH, KUBS)
- Korean Medicine AI integration pilot projects
- Silicon Valley-Korea network expansion leveraged

# STRATEGIC INSIGHTS

1. **Silicon Valley Validation - StartX Endorsement:**
   - Andrew Radin's personal endorsement represents top-tier Silicon Valley validation
   - StartX acceptance would provide premier accelerator credentials
   - Opens doors to Stanford ecosystem and Silicon Valley investor network
   - Demonstrates Erudio Bio's standing among elite Silicon Valley AI/biotech companies

2. **Venture Capital Market Validation:**
   - Path Way Investment's Series A commitment validates market appetite
   - 110-minute meeting duration (vs. 60-minute schedule) indicates genuine investor interest
   - Executive Director ë¬¸ì´ˆí˜œ's audacious business model proposal (preclinical + clinical stage expansion) significantly enlarges TAM
   - Korean VC market receptivity extremely positive

3. **Academic Network as Strategic Asset:**
   - SNU EE seminar's exceptional success (long post-event networking line) demonstrates strong academic community engagement
   - Multiple top-tier universities engaged (SNU, POSTECH, KUBS, KAIST connections)
   - Academic partnerships provide:
     - Research collaboration potential
     - Talent pipeline access
     - Credibility and validation
     - K-PAI platform expansion opportunities

4. **Regulatory Pathway Clarity:**
   - Biochip medical equipment categorization is critical for proper MFDS approval pathway
   - G-Quantum Bio Forum regulatory/legal seminar provided comprehensive framework
   - 20-year industry veteran (ì´í™êµ­, Asia Medical) insights invaluable for market navigation
   - IRB iterative process understanding (ì†¡ì¬ì§„ advice) prevents perfectionism paralysis

5. **Media Strategy Paying Dividends:**
   - ê¹€ì†Œì—° interview investment yielded two major articles including Gates Foundation feature
   - Press strategy validated: frequent exposure approach confirmed as optimal
   - Media coverage reinforces investor confidence and market credibility

6. **Korean Medicine - Untapped Market:**
   - í•œì˜í•™ exists uniquely in South Korea - represents differentiated market opportunity
   - AI TF advisory role provides inside track to this specialized market
   - Potential for first-mover advantage in Korean Medicine AI integration

7. **Network Effects Compounding:**
   - Middle school friend (ì„±íƒœì›…) connection led to critical medical equipment insights
   - Gauss Labs alumni network (ì´ë³‘ì°¬, ì¡°ì—°í¬) providing ongoing value
   - James Rhee humanities connection expands interdisciplinary perspective
   - Each networking investment generating future returns

8. **Dual Entity Strategy Working:**
   - â‚©500M angel investment in Korea entity enables aggressive local execution
   - USD 140k US entity investment maintains Silicon Valley momentum
   - Path Way Series A commitment for US entity positions for scale
   - Korea entity as Asia market entry point validated

9. **G-Quantum Bio Forum - Major Strategic Event:**
   - 3-day immersion provided:
     - Andrew Radin StartX connection (breakthrough outcome)
     - Silicon Valley-Korea network bridging (ì´ì‹œì—°, ì„ì„±ì›, ë°•êµ°í˜¸)
     - Regulatory/legal comprehensive education
     - Government relations (ê¹€ì„±ì§„, Suwon City)
     - Bio/medical industry landscape visibility
   - Demonstrates value of premier industry events for network acceleration

10. **Time Investment in Relationship Building:**
    - Multiple dinners, coffee chats, and networking sessions paying long-term dividends
    - Semiconductor industry insights from ì±„ê´€ì—½ (multiple meetings) building deep understanding
    - Patient capital approach to network building validated

# KEY MEETINGS & OUTCOMES

## 16-Sep-2025 - Strategic Planning & Business Development

### 7pm-8:30pm - Evening - Business Development Networking Dinner

<h4>Attendee</h4>

- Sunghee Yun
- **ì´ìƒì—½** (Vice Chairman, Korea SME Association - Korea Strong Small and Medium Enterprises Association (í•œêµ­ê°•ì†Œê¸°ì—…í˜‘íšŒ))

<h4>Outcomes</h4>

- Established potential network contact for Erudio Bio business development
- Identified influential connection throughout Korea Strong Small and Medium Enterprises Association)
- He has his own startup with novel ideas - potential synergies

### 9pm-11pm - After Dinner - Strategic Meeting with Jin Young Heo

<h4>Attendees</h4>

- Sunghee Yun
- Jin Young Heo (CLO, Erudio Bio Korea)

<h4>Discussion Topics</h4>

- General Erudio Bio strategies (SNUBH, Jeonbuk progress review)
- **G-Quantum Bio Conference planning** (Sep 22-24 @ Suwon Convention Center)
  - Jin Young to attend Day 2 (Sep 23)
  - Sunghee to invite Jin Young to K-BioX Mentoring Sessions, G-BIVA Innovation Salon, Conference Dinner

## 17-Sep-2025 - POSTECH AI Seminar & Robotics Collaboration

### 12:30pm-2pm - AI Seminar for POSTECH students

<h4>Location</h4>

Pohang University of Science and Technology (POSTECH)

<h4>Title</h4>

"The AI Landscape Decoded - Where We Are, Where We're Going"
[abstract](https://sungheeyun.github.io/seminars/2025_0917%20KST%20-%20POSTECH%20Creativity%20IT%20Seminar%20-%20The%20AI%20Landscape%20Decoded%20-%20Where%20We%20Are,%20Where%20We're%20Going/abstract){:target="_blank"}

**Invited by** í•œìˆ˜í¬ êµìˆ˜ (Associate Professor, Creative IT Engineering / Electrical Engineering; Director, Unmanned Vehicle Research Institute, POSTECH)

### 5pm-6:45pm - Networking Dinner

<h4>Attendee</h4>

- Sunghee Yun
- í•œìˆ˜í¬ êµìˆ˜ (Associate Professor, Creative IT Engineering / Electrical Engineering; Director, Unmanned Vehicle Research Institute, POSTECH)

<h4>Outcomes</h4>

- Gained deep insights into:
  - Robotics technology trends
  - Edge computing applications
  - AI technology developments in robotics field
- Proposed potential collaboration with Erudio Bio
- Fruitful conversation providing valuable AI/robotics trend insights

## 18-Sep-2025 - Dual AI Seminars: Major Academic Engagement

### 10:30am-12pm - Morning - Korea University Business School (KUBS)

<h4>AI Seminar for KUBS Studetns</h4>

<h4>Title</h4>

"The AI Revolution - How Smart Systems Are Reshaping Industries and Executive Decision-Making"
[abstract](https://sungheeyun.github.io/seminars/2025_0918%20KST%20-%20KUBS%20Special%20AI%20Lecture%20-%20The%20AI%20Revolution%20-%20How%20Smart%20Systems%20Are%20Reshaping%20Industries%20and%20Executive%20Decision-Making/abstract){:target="_blank"}

**Invited by** ê¹€ê¸°í›ˆ êµìˆ˜ (Graduate School of Business, Korea University)

### 12pm-2pm - Lunch Meeting with ê¹€ê¸°í›ˆ êµìˆ˜

<h4>Discussion</h4>

Potential collaboration with Erudio Bio & K-PAI

<h4>Outcome</h4>

Established relationship with KUBS for potential partnerships

### 4:30pm-6:30pm - Afternoon &amp; Evening - SNU EE 4ê³¼ì„¸ë¯¸ë‚˜

<h4>Title</h4>

"AI Pulse Check - What Silicon Valley Is Actually Building Right Now"
[abstract](https://sungheeyun.github.io/seminars/2025_0918%20KST%20-%20SNU%20ECS%20Four-Departments%20Joint%20Seminar%20-%20AI%20Pulse%20Check%20-%20What%20Silicon%20Valley%20Is%20Actually%20Building%20Right%20Now/abstract){:target="_blank"}

**Invited by** í™ìš©íƒ êµìˆ˜ (Professor & Department Chair, Electrical and Computer Engineering, Seoul National University)

<h4>Pre-Seminar Activity</h4>

15-minute tea time with í™ìš©íƒ êµìˆ˜

<h4>CRITICAL OUTCOMES - EXTREMELY SUCCESSFUL EVENT</h4>

- **Exceptional audience engagement:**
	- Strong eye contact and active participation throughout
	- Numerous insightful questions during seminar
- **Long line of attendees post-seminar** wanting to:
	- Introduce themselves personally
	- Exchange contact information
	- Establish ongoing professional connections

### 7pm-8:30pm - Dinner Meeting

<h4>Attendees</h4>

- Sunghee Yun
- í™ìš©íƒ êµìˆ˜
- ê¹€ì˜ë¯¼ êµìˆ˜ (Associate Professor, Electrical and Computer Engineering, Seoul National University)

<h4>Discussion & Outcomes</h4>

- Explored collaboration opportunities for Erudio Bio and K-PAI
- Gained valuable academic insights from SNU professors

### 9:15pm-11:30pm - Night - Semiconductor Industry Deep Dive

<h4>Attendee</h4>

- Sunghee Yun
- ì±„ê´€ì—½ ìƒë¬´ (Master, S.LSI Digital IP Development Team, Samsung Electronics)

<h4>Outcomes</h4>

Gained comprehensive insights into semiconductor business landscape
- High Bandwidth Memory (HBM) business dynamics
- Samsung and worldwide foundry business
- Current and future AI landscape implications for semiconductor industry

## 19-Sep-2025 - Media Relations & Medical Equipment Regulatory Strategy

### 2:30pm-4:00pm - Media Interview - STRATEGIC INVESTMENT

<h4>Attendee</h4>

- Sunghee Yun
- ê¹€ì†Œì—° ê¸°ì (Deputy Manager, Information Media Science, Money Today)

<h4>Discussion</h4>

- Comprehensive AI landscape overview
- Differentiated insights unique to Sunghee's Silicon Valley perspective
- Agreement to meet again in Silicon Valley

<h4>CRITICAL OUTCOMES</h4>

- **Article published** - [ë¨¸ë‹ˆíˆ¬ë°ì´ ê¸°ì‚¬](https://n.news.naver.com/article/008/0005264969?type=journalists){:target="_blank"}
- **Major follow-up article** - [Gates Foundation Erudio Bio Interview](https://www.mt.co.kr/tech/2025/12/15/2025121200524048774){:target="_blank"}
- **Strategic assessment** - Significant media exposure investment that paid off big time!

### 4:30pm-5:30pm - Afternoon Coffee Chat - Gauss Labs Alumni Network

<h4>Attendee</h4>

- Sunghee Yun
- ì´ë³‘ì°¬ (Former Senior Applied Scientist at Gauss Labs; currently Postdoc under ì‹ ì§„ìš° êµìˆ˜, KAIST)

<h4>Purpose</h4>

General networking, maintain Gauss Labs alumni connections

### 7pm-9pm - Evening - Medical Equipment Distribution & Regulatory Insights

<h3>Attendees</h3>

- Sunghee Yun
- Jin Young Heo (CLO, Erudio Bio Korea)
- ì´í™êµ­ (CEO, Asia Medical - ì•„ì‹œì•„ë©”ë””ì¹¼)
- ê¹€ì •êµ­ (Director, Regional Media Support / Newspaper Distribution Team, Korea Press Foundation)

**Arranged by** ì„±íƒœì›… (Sunghee's middle school friend)

<h4>CRITICAL OUTCOMES & INSIGHTS</h4>

- **Product categorization identified** - Erudio's VSA platform is categorized as **biochip medical equipment**
- **Regulatory pathway clarity** - Must investigate MFDS (KFDA) approval procedures specifically for biochip medical equipment
- **Documentation requirements** - Need to understand MFDS product definition and categories for proper regulatory pathway
- **Industry veteran perspective** - 20 years distribution experience provided invaluable market insights

<h4>Assessment</h4>

Extremely fruitful, instructive, helpful, and informative meeting

### 9pm-11:30pm - Night - Networking with POSTECH Professor

<h4>Attendee</h4>

- Sunghee Yun
- ìœ¤ê±´ìˆ˜ êµìˆ˜ (Professor, Physics Department, POSTECH)

<h4>Outcomes</h4>

- Gained comprehensive insights into physics
- Established potential collaboration relations with POSTECH

## 20-Sep-2025 - Angel Investment Finalization & IRB Strategy

### 9am-10:30am - Angel Investment Breakfast - MAJOR WIN

<h4>Attendee</h4>

- Jinsul Joo (Angel investor)

<h4>CRITICAL OUTCOME</h4>

- Meeting initiated relationship
- Multiple follow-up meetings conducted
- **Eventually led to â‚©500M (500 million won) angel investment in Erudio Bio Korea, Inc.**

### 10:30am - Phone Call - IRB Process Strategy

<h4>Attendee</h4>

- Sunghee Yun
- ì†¡ì¬ì§„ êµ êµìˆ˜ (Associate Professor, Clinical Medicine, Seoul National University Bundang Hospital)

<h4>CRITICAL STRATEGIC INSIGHT</h4>

- IRB approval is **iterative process**
- **Key recommendation** - Don't aim for perfection on first submission
- **Action** - Submit first draft to SNUBH to initiate conversation and process flow

### 12pm-1pm - Lunch - Recruitment Networking

<h4>Attendee</h4>

- Sunghee Yun
- ìœ¤ì„±í˜¸ (Recruiter)

<h4>Purpose</h4>

Potential recruitment support and general networking

### 6pm-8pm - Evening - Industry Networking Dinner

<h4>Attendees</h4>

- ì´ê²½í™˜ (CEO, KHAN; former Samsung employee)
- ë°•ì¤€ì˜ (CEO, í•œë°˜ë„; Yonsei Engineering, Economics MA, Cultural Anthropology PhD; Samsung Electronics Technology Advisory Professor for Semiconductor)
- ìµœìš± (Team Leader PM&SE, BOS Semiconductors)
- ì—„íš¨ì„­ (Team Leader, Innovation Talent Development Center, Incheon National University; bio/medical business involvement)

<h3>Outcome</h3>

- Received medical equipment booklet from ì—„íš¨ì„­
- Delivered booklet to Jin Young Heo same evening for review

### 9pm-10:45pm - Night - Customer Story Development

<h4>Location</h4>

Jin Young Heo's house

<h4>Attendees</h4>

- Sunghee Yun
- Jin Young Heo (CLO, Erudio Bio Korea)
- í™©í˜œë ¨ (Jin Young's wife)

<h4>Purpose</h4>

Develop customer story narratives for business development materials

## 21-Sep-2025 - Press Strategy & Korean Medicine Collaboration

### 12pm-1:30pm - Lunch - Press Strategy Planning

<h4>Attendees</h4>

- ì¡°ì‹œì˜ (Team Leader, Securities Capital Markets IB Team, Asia Economy)
- Sunghee Yun
- Jin Young Heo (CLO, Erudio Bio Korea)

<h4>CRITICAL DECISION & STRATEGY</h4>

- **Press strategy** - Expose Erudio Bio to media as frequently as possible
- **Action decided** - Prepare press materials and deliver to ì¡°ì‹œì˜

<h4>OUTCOMES</h4>

The meeting eventually led to [this press exposure](https://www.asiae.co.kr/article/2025103008554006190){:target="_blank"}

### 3pm-4pm - Afternoon - AI/Cryptography Collaboration

<h4>Attendee</h4>

- Sunghee Yun
- ê¹€ì„¤ê¸° (AI Â· Privacy Â· Data Consultant)

<h4>Purpose</h4>

Explore potential AI/cryptography collaboration and general networking

### 6pm-7:30pm - Evening - Korean Medicine Collaboration

<h4>Attendees</h4>

- Sunghee Yun
- ì •ìœ ìš© (Senior Vice President, Korean Medical Association - ëŒ€í•œí•œì˜ì‚¬í˜‘íšŒ)
- í™ìŠ¹í›ˆ (Senior Engineer, SK Hynix)

<h4>Discussion</h4>

- Potential collaboration opportunities in í•œì˜í•™ (Korean traditional medicine)
- **Strategic note:** í•œì˜í•™ is unique medical science class existing only in South Korea
- Represents untapped market opportunity

## 22-Sep-2025 - 24-Sep-2025: G-Quantum Bio Forum - LANDMARK EVENT

**Location** - Suwon Convention Center
**Duration** - 3-day forum

## 22-Sep-2025 (Day 1) - Forum Opening & Networking

### Daytime

Attended cutting-edge bio/medical technology & research presentations

### 6pm-9pm - Evening - Networking Dinner

<h4>Attendees</h4>

- Multiple public servants (forum organizers, planners, executors)
- CEOs and CTOs from bio/medical fields

<h4>Outcomes</h4>

- Established connections with forum organizers
- Networked with bio/medical industry leaders
- Made acquaintance with ê¹€ì„±ì§„ ê³¼ì¥ (Manager, Suwon City Government)

<h4>Post-Dinner Activity</h4>

- Suwon castle and city night tour
- Experienced beautiful nighttime landscape of historic Suwon

## 23-Sep-2025 (Day 2) - BREAKTHROUGH DAY

### 10am-12pm - Morning - K-BioX Mentoring Event

<h4>CRITICAL MEETING - Andrew Radin (AI Head, StartX) - MAJOR STRATEGIC WIN</h4>

**Meeting Type** - In-person, face-to-face, personal meeting

<h4>CRITICAL OUTCOMES</h4>

- **StartX Program Endorsement**
   - Andrew Radin **personally advised Sunghee to apply for StartX program**
   - Andrew's endorsement **essentially guarantees acceptance**
   - Major Silicon Valley accelerator validation

- **Successful Pitch Execution**
   - Emphasized Erudio Bio's technical excellence
   - Highlighted entrepreneurial strength
   - Showcased strategic positioning
   - Presented business model
   - **Featured Gates Foundation Award prominently**
   - **Self-assessment** - "I did quite well on that pitch!"

- **Strategic Impact**
   - Connection to one of Silicon Valley's most influential AI leaders
   - Path to premier accelerator program
   - Validation from top-tier Silicon Valley ecosystem

<h4>Silicon Valley Network Expansion</h4>

**Introduced by Sunghee to Jin Young Heo:*
- ì´ì‹œì—° ë°•ì‚¬ (K-BioX Representative Operating Committee Member, Stanford Medical School)
- ì„ì„±ì› ëŒ€í‘œ (CEO, ImpriMed)
- ë°•êµ°í˜¸ ëŒ€í‘œ (CEO, PathoBrainSeq)

<h4>Outcome</h4>

Expanded Jin Young's Silicon Valley network with key biotech contacts

### 12pm-1pm - Special Lunch (Invitee-Only)

- Sunghee secured Jin Young Heo's attendance through special request
- Executive-level networking opportunity

### 3pm-6pm - Afternoon - G-BIVA Innovation Salon (Exclusive Invitees-Only Event)

- Sunghee secured Jin Young Heo's attendance through special permission
- Presented Erudio Bio, Inc. to exclusive audience
- Learned from other CEOs' presentations
- High-level strategic discussions

### 7pm-9pm - Evening - Conference Main Dinner

- Extensive networking with students and K-BioX members
- Post-dinner - Special Suwon village tour

## 24-Sep-2025 - Regulatory & Legal Deep Dive

<h4>All-Day Event</h4>

Regulatory Science Conference and Legal Strategy Seminar

<h4>Attendees</h4>

- Sunghee Yun (virtual)
- Jin Young Heo (virtual)

<h4>Program</h4>

[PDF](https://sungheeyun-photos-01.github.io/resource/2025/09/22-24%20-%20G-Quantum%20Bio/program/Program%20-%20Regulatory%20Science%20Conference%20and%20Legal%20Strategy%20Seminar.pdf){:target="_blank"}

<h4>10pm-12:10pm - Morning Session - ê·œì œê³¼í•™ ì»¨í¼ëŸ°ìŠ¤</h4>

- Bioequivalence and regulatory guidelines
- Research development for regulatory approval
- AI application in drug development processes

<h4>1:30pm-4:30pm - Afternoon Session - ë²•ë¥  ì „ëµ ì„¸ë¯¸ë‚˜</h4>

- IPO and legal strategies for biotech companies
- IP licensing and legal frameworks
- Data/privacy legal considerations
- Investment structures and exit strategies

<h4>CRITICAL OUTCOMES</h4>

Comprehensive understanding of
- **MFDS/KFDA regulatory pathways** for medical devices
- Legal frameworks for biotech companies in Korea
- IP strategy for medical device commercialization
- Investment and exit planning considerations
- All relevant regulatory requirements for Erudio Bio's product category

### 7pm-8:30pm - Evening - Recruitment Strategy

<h4>Attendee</h4>

- Sunghee Yun
- ì¡°ì—°í¬ (TL/Talent Acquisition Specialist, SK Hynix; former Gauss Labs recruiter)

<h4>Purpose</h4>

Explore potential collaboration for Erudio Bio Korea recruitment needs

## 25-Sep-2025 - Venture Capital Breakthrough & Strategic Partnerships

### 2pm-3:50pm - Path Way Investment VC Meeting - LANDMARK OUTCOME

<h4>Location</h4>

425 Eonju-ro, Gangnam District, Seoul

<h4>Attendees</h4>

- **Erudio Bio**
  - Sunghee Yun
- **Path Way Investment**
  - ì´ìƒì§„ ëŒ€í‘œ (CEO, Path Way Partners)
  - ë¬¸ì´ˆí˜œ ì „ë¬´ì´ì‚¬ (Executive Director / Ph.D. Engineering / Adjunct Professor, Molecular Medicine & Biopharmaceuticals, Seoul National University, Path Way Investment)
  - ë°•ìœ¤í˜¸ íˆ¬ìê¸°íšì‹¤ ëŒ€ë¦¬ (Deputy Director, Investment Planning / Research Analyst, Path Way Partners)

**Introduced and Arranged by** í¸ì¬í˜¸ êµìˆ˜ (San Jose State University)

<h4>Scheduled Duration</h4>

60 minutes

<h4>Actual Duration</h4>

**110 minutes** (engagement so strong no one noticed time)

<h4>CRITICAL OUTCOMES</h4>

- **Technology Deep Dive & Business Model Expansion**
   - ë¬¸ì´ˆí˜œ ì „ë¬´ì´ì‚¬ asked highly sophisticated technology questions
   - **AUDACIOUS BUSINESS MODEL PROPOSED**
     - **Beyond lead optimization stage** (current assumption)
     - **VSA could contribute to preclinical stage**
     - **VSA could even contribute to clinical stage**
   - **Strategic impact** - Significantly expands Erudio Bio's total addressable market
- **Series A Commitment**
   - Several days post-meeting - Received text from **ì´ìƒì§„ CEO**
   - **Path Way confirmed interest in participating in Erudio Bio Series A fundraising round**
- **Strategic Validation - MAJOR WINS**
   - Confirmed market responds **very favorably** to Erudio Bio
   - Validated tech/market strategy is sound and compelling
   - Added high-caliber Korean VC to investor network
   - Expanded understanding of VSA platform's market potential

<h4>Assessment</h4>

Meeting exceeded all expectations - technology validation, business model expansion, and investor commitment achieved

### 6pm-8pm - Evening - Pion Corporation Partnership Exploration

<h4>Dinner Attendees</h4>

- Sunghee Yun
- Jin Young Heo (CLO, Erudio Bio Korea)
- ì „ì°¬ì„ ëŒ€í‘œ (CEO, VCAT.AI, Pion Corporation)

<h4>Purpose</h4>

- General networking
- Explore potential technical partnership with Pion Corporation

### 9pm-11pm - Night - Semiconductor Industry Insights (Part 2)

<h4>Location</h4>

ì±„ê´€ì—½'s house

<h4>Attendees</h4>

- Sunghee Yun
- Jin Young Heo
- ì±„ê´€ì—½ (Master, S.LSI Digital IP Development Team, Samsung Electronics)

<h4>Purpose</h4>

- General networking
- Continued semiconductor industry insights and networking (follow-up to Sep 18 meeting)

## 26-Sep-2025 - Angel Investment Finalization & Korean Medicine AI Initiative

### 12pm-1pm - Lunch - D.Notitia Partnership Discussion

<h4>Attendees</h4>

- Sunghee Yun
- Jin Young Heo
- ì •ë¬´ê²½ (CEO, D.notitia)
- ì†ì¤€í˜ (COO / VP / Co-Founder, D.notitia)

<h4>Purpose</h4>

General networking and explore potential partnership opportunities

### **Evening: Angel Investment Terms Finalization**

<h4>Attendee</h4>

- Sunghee Yun
- **Angel Investor** (Sunghee's High School Senior - USD 140k commitment)

<h4>CRITICAL OUTCOME</h4>

- Discussed and finalized investment terms
- Obtained investor's specific requests
- **Immediately communicated details to Kee-hyun Paik** for execution

### 7:30pm-12am - Night - [Association of Korean Medicine] 2nd Korean Medicine-AI Integration Task Force Meeting - MAJOR ENGAGEMENT

<h4>Event</h4>

[Association of Korean Medicine (ëŒ€í•œí•œì˜ì‚¬í˜‘íšŒ)] 2nd Korean Medicine-AI Integration Task Force Meeting


<h4>Role</h4>

AI Task Force Advisory Committee Member

<h4>Activity</h4>

- Delivered AI talk to Korean Medicine Association AI Task Force
	- "From Silicon Valley to Biotech Valley - How Agentic AI is Reshaping Drug Discovery"
	[abstract](https://sungheeyun.github.io/seminars/2025_0926%20KST%20-%20Korean%20Medicine%20AI%20Integration%20TF%20-%20From%20Silicon%20Valley%20to%20Biotech%20Valley%20-%20How%20Agentic%20AI%20is%20Reshaping%20Drug%20Discovery/abstract){:target="_blank"}
- **Response** Amazing engagement from all committee members

<h4>Attendees Met</h4>

- Multiple í•œì˜ì‚¬ (Korean medicine doctors)
- í•œë°©ë³‘ì› ì›ì¥ë‹˜ë“¤ (Korean medicine hospital directors)
- AI Task Force members

<h4>Post-Meeting Networking</h4>

- Participated in chicken & beer networking session
- Further relationship building with Korean medicine community

<h3>Outcome</h3>

Deepened engagement with Korean medicine AI integration initiative - unique market opportunity

## 27-Sep-2025 - Humanities & Social Sciences Networking, Return to US

### 2pm-4pm - Afternoon - Humanities & Social Sciences Gathering

**Invited by** James Rhee (Johnson Chair of Entrepreneurship; Owner, CEO, and Author @ red helicopter)

<h4>Attendees</h4>

- Professors and academics
- Humanities and social sciences experts

<h4>Discussion</h4>

Humanities and social sciences issues and perspectives

<h4>Purpose</h4>

General networking, interdisciplinary perspective building

### **Evening: Return to Silicon Valley**

Flight: OZ 212, ICN â†’ SFO (departed 8:55pm KST, arrived 3:30pm PDT same day)

# FUNDRAISING

## Angel Investment Secured - USD 140k

**Investor** Sunghee's High School Senior

**Timeline**
- 20-Sep-2025 - Initial breakfast meeting
- 26-Sep-2025 - Terms finalized
- **Amount** - USD 140,000

**Status** <span style="color: green;">**Terms finalized, pending execution**</span>

## Angel Investment Under Negotiation - â‚©500M

**Investor** Jinsul Joo

**Timeline**
- 20-Sep-2025 - Initial breakfast meeting initiated relationship
- Multiple follow-up meetings conducted
- **Amount** - â‚©500,000,000 (500 million won)

**Status** - <span style="color: green;">**Considering Investment for Erudio Bio Korea, Inc.**</span>

## Series A Commitment - Path Way Investment

**Investor** - Path Way Partners/Investment

**Key Contact** - ì´ìƒì§„ ëŒ€í‘œ / ë¬¸ì´ˆí˜œ ì „ë¬´ì´ì‚¬

**Timeline**
- 25-Sep-2025 - Initial meeting (110-minute deep dive)
- Post-meeting - Text confirmation of Series A interest

**Status** - <span style="color: blue;">**Commitment obtained, timing TBD**</span>

# PARTNERSHIP

## StartX Program - Silicon Valley Accelerator

**Contact** - Andrew Radin (AI Head, StartX)

**Outcome** - Personal endorsement and application recommendation (essentially guarantees acceptance)

**Status** - <span style="color: red;">**Pending application submission**</span>

## Korean Medicine AI Integration

**Organization** - Korean Medical Association

**Role** - AI Task Force Advisory Committee Member

**Status** - <span style="color: blue;">**Active ongoing engagement**</span>

## Pion Corporation Technical Partnership

**Contact** - ì „ì°¬ì„ ëŒ€í‘œ (CEO, VCAT.AI, Pion Corporation)

**Status** - <span style="color: blue;">**Initial discussion, exploring opportunities**</span>

## D.Notitia Partnership

**Contacts** - ì •ë¬´ê²½ (CEO), ì†ì¤€í˜ (COO/VP/Co-Founder)

**Status** - <span style="color: blue;">**Having maintained good relationship for a long time, exploring opportunities**</span>

# NETWORKING

## POSTECH Faculty Network

**Contact** - í•œìˆ˜í¬ êµìˆ˜ (Associate Professor, Director of Unmanned Vehicle Research Institute, POSTECH)

**Focus** - Robotics, edge computing, AI technology collaboration potential

## Korea University Business School (KUBS)

**Contact** - ê¹€ê¸°í›ˆ êµìˆ˜ (Professor, Graduate School of Business)

**Focus** - K-PAI and Erudio Bio collaboration opportunities

## Seoul National University (SNU) EE Department

**Contacts**
- í™ìš©íƒ êµìˆ˜ (Department Chair, Electrical and Computer Engineering)
- ê¹€ì˜ë¯¼ êµìˆ˜ (Associate Professor, Electrical and Computer Engineering)

**Outcome** - Extremely successful seminar with exceptional audience engagement, extensive post-seminar networking

## Silicon Valley-Korea Bridge

**G-Quantum Bio Forum Connections:**
- ì´ì‹œì—° ë°•ì‚¬ (K-BioX Representative, Stanford Medical School)
- ì„ì„±ì› ëŒ€í‘œ (CEO, ImpriMed)
- ë°•êµ°í˜¸ ëŒ€í‘œ (CEO, PathoBrainSeq)

## Media Relations

**Contact** - ê¹€ì†Œì—° (Deputy Manager, Money Today)

**Outcome** - Two published articles including Gates Foundation feature

## Korean SME Association

**Contact** - ì´ìƒì—½ (Vice Chairman, Korea Strong Small and Medium Enterprises Association)

**Potential** - Business development network throughout Korean SME ecosystem

## Recruitment Network

**Contacts**
- ìœ¤ì„±í¬ (Recruiter)
- ì¡°ì—°í¬ (TL/Talent Acquisition Specialist, SK Hynix; former Gauss Labs)

## Humanities & Social Sciences

**Contact** - James Rhee (Johnson Chair of Entrepreneurship @ red helicopter)

**Network** - Professors and experts in humanities and social sciences

**Report prepared by** Sunghee Yun
<br>
**Initial draft on** 04-Jan-2026
<br>
**Final Revised on** 04-Jan-2026
